scholarly journals Medicine Identification New Database (MIND): A quick, simple and accurate tool for the identification of unlabelled medication in hospital pharmacies

2021 ◽  
pp. 24
Author(s):  
Elsa Reallon ◽  
Anne-Laure Yailian ◽  
Chloé Marchand ◽  
Samira Filali ◽  
Camille Merienne ◽  
...  
Keyword(s):  
Hospital Pharmacies

scholarly journals Using Design Thinking Principles to Improve Outpatients’ Experiences in Hospital Pharmacies: A Case Study of Two Hospitals in Asir Region, Saudi Arabia

Healthcare ◽  
2021 ◽  
Vol 9 (7) ◽  
pp. 854
Author(s):  
Dalia Almaghaslah ◽  
Abdulrhman Alsayari ◽  
Saleh Ali Alyahya ◽  
Rana Alshehri ◽  
Khawlah Alqadi ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
Problem Solving ◽  
Management System ◽  
Design Thinking ◽  
Queue Management ◽  
End User ◽  
Study Results ◽  
Hospital Pharmacies ◽  
Asir Region

Introduction: Design thinking, an innovative problem-solving approach, has gained wide popularity in healthcare disciplines. The aim of this work is to improve outpatients’ experiences in hospital pharmacies in two hospitals in Asir region, Saudi Arabia. Methods: The design thinking approach, adopted from Stanford University’s D-School, was used in this study. Results: Several problems were identified: lack of comfortable environment in the pharmacies’ waiting area, lack of a queue management system, and workflow inefficiencies related to ordering and supplies of medicines. A prototype was proposed to overcome these challenges. Discussion and Conclusion: The design thinking approach helped in identifying end-user (patients visiting outpatient pharmacies) values and desires and provided an understanding of their struggles. It also proposed tailored solutions that could improve patients’ experiences while using the services of the outpatient pharmacies.

scholarly journals Defining clinical pharmacy and support activities indicators for hospital practice using a combined nominal and focus group technique

2021 ◽  
Author(s):  
Hugo Lopes ◽  
Andrea Rodrigues Lopes ◽  
Helena Farinha ◽  
Ana Paula Martins
Keyword(s):  
Clinical Pharmacy ◽  
Performance Indicators ◽  
Outcome Measure ◽  
Expert Panel ◽  
Future Perspectives ◽  
National Scale ◽  
Professional Accountability ◽  
Comprehensive Literature Review ◽  
Hospital Pharmacies ◽  
Crucial Part

AbstractBackground Although clinical pharmacy is a crucial part of hospital pharmacist’s day-to-day activity, its performance is not usually subject to a holistic assessment. Objective To define a set of relevant and measurable clinical pharmacy and support activities key performance indicators (cpKPI and saKPI, respectively). Setting Portuguese Hospital Pharmacies. Method After a comprehensive literature review focusing on the metrics already in use in other countries, several meetings with directors of hospital pharmacies were conducted to obtain their perspectives on hospital pharmacy practices and existing metrics. Finally, five rounds with a panel of 8 experts were performed to define the final set of KPIs, where experts were asked to score each indicator’ relevance and measurability, and encouraged to suggest new metrics. Main outcome measure The first Portuguese list of KPIs to assess pharmacists’ clinical and support activities performance and quality in hospital pharmacies. Results A total of 136 KPIs were assessed during this study, of which 57 were included in the original list and 79 were later added by the expert panel. By the end of the study, a total of 85 indicators were included in the final list, of which 40 are considered to be saKPI, 39 cpKPI and 6 neither. Conclusion A set of measurable KPIs was established to allow for benchmarking within and between Portuguese hospital Pharmacies and to elevate professional accountability and transparency. Future perspectives include the use of both cpKPIs and saKPIs on a national scale to identify the most efficient performances and areas of possible improvement.

scholarly journals Validation of an HPLC Assay Method for Routine QC Testing and Stability Study of Compounded Low-Dose Capsules of Acetylsalicylic Acid

2018 ◽  
Vol 3 (4) ◽  
pp. 199-206
Author(s):  
Nelly Lonca ◽  
Fabienne Maillard ◽  
Géraldine Leguelinel ◽  
Tahmer Sharkawi ◽  
Ian Soulairol
Keyword(s):  
Acetylsalicylic Acid ◽  
Orthophosphoric Acid ◽  
Low Dose ◽  
Stability Study ◽  
Assay Method ◽  
Stability Studies ◽  
Physicochemical Stability ◽  
Hospital Pharmacies ◽  
Provocation Testing ◽  
Low Dosage

Abstract Background The intolerance to Acetylsalicylic Acid (ASA) can be detected by conducting oral provocation testing (OPT), which is to gradually introduce low doses of ASA. To perform this test, hospital pharmacies compound small batches of different low-dosage ASA capsules. This work aims to validate a method for fast HPLC-UV assay that allows routine quality control and physicochemical stability studies of capsules. Methods The chromatographic separation is performed using a C18 column Kinetex (100 A, 50×4.6 mm, 2.6 µm) equipped with a precolumn C18. Separation is achieved using a mobile phase composed of water-acetonitrile-orthophosphoric acid (68:32:0.2 v/v/v) at a flow rate of 0.8 mL/min and UV detection at 237 nm. Results Validation shows that the method was suitable for routine analysis and could be used to perform stability studies. Conclusions The 5, 25, 100 and 250 mg dosed capsules show acceptable stability over 12 months, while the 1 mg dosed capsule show an unacceptable degradation of more than 15 % after 3 months. Therefore, hospital pharmacy can plan the manufacture of capsules and anticipate the requests of doctors.

scholarly journals Pseudomonas aeruginosa in hospital pharmacies.

BMJ ◽  
1976 ◽  
Vol 1 (6008) ◽  
pp. 511-512 ◽  
Author(s):  
R M Baird ◽  
W R Brown ◽  
R A Shooter
Keyword(s):  
Pseudomonas Aeruginosa ◽  
Hospital Pharmacies

scholarly journals The status of Iranian hospital pharmacies according to age-friendly pharmacies criteria

2017 ◽  
Vol 8 (4) ◽  
pp. 120
Author(s):  
Ali Tahernezhad ◽  
Peivand Bastani ◽  
MiladAhmadi Marzaleh ◽  
Mina Dehghani ◽  
Maryam Falahatzadeh ◽  
...  
Keyword(s):  
Hospital Pharmacies ◽  
The Status

scholarly journals Survey of delivery of prophylactic immunoglobulins following exposure to a measles case

2012 ◽  
Vol 17 (39) ◽  
Author(s):  
A Bernier ◽  
C Le Goaster ◽  
H Peigue-Lafeuille ◽  
D Floret
Keyword(s):  
Pregnant Women ◽  
Response Rate ◽  
Postal Survey ◽  
Health Authorities ◽  
Laboratory Confirmation ◽  
Hospital Pharmacies ◽  
French Hospital ◽  
One Year ◽  
Available Information ◽  
Polyvalent Immunoglobulins

In France, almost 23,000 cases of measles and 10 deaths have been reported between January 2008 and August 2012. French health authorities recommend delivery of human polyvalent immunoglobulins in the event of exposure to a measles case for some categories of unvaccinated persons (children under the age of 12 months, immunocompromised persons and pregnant women), within six days after exposure and following laboratory confirmation of the contact case. We carried out a postal survey among 368 French hospital pharmacies to evaluate the number of persons affected by this measure between 1 January 2010 and 31 August 2011, to describe the characteristics of these patients and to evaluate the application of the recommendations in terms of delay between exposure and immunoglobulin delivery, and confirmation of the contact case. The response rate to the survey was 73%. In total, 400 immunoglobulin deliveries were listed, most of them for children under the age of one year, and 84% of the 250 administrations with available information occurred within six days after exposure, as recommended. However, only 48% of the 209 treated contacts with available information were laboratory-confirmed when the immunoglobulins were delivered. This survey is the first evaluation of this recommendation since its introduction in 2005 and suggests that the recommendations may need to be updated.

Sign in / Sign up

Export Citation Format

Share Document